Johnson & Johnson Strengthens Neuroscience Leadership with …

4 days ago · New Brunswick, N.J. and Bedminster, N.J., January 13, 2025 – Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have …

$14
OFF

J&J Buys Intra-Cellular In $14.6 Billion Deal, Delving Further Into ...

1 week from now

4 days ago · Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. The …

apnews.com

$14
OFF

J&J Doubles Down On Neurological Drugs With $14.6 Billion Intra ...

1 week from now

4 days ago · Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its …

reuters.com

$14
OFF

Johnson & Johnson Acquires Intra-Cellular In $14.6 Billion Deal

1 week from now

4 days ago · Johnson & Johnson will acquire Intra-Cellular for $132 per share in cash, a 39 percent premium over Intra-Cellular's Friday closing price of $94.87. Following the …

newsweek.com

$14
OFF

J&J To Acquire Intra-Cellular For About $14.6 Billion

1 week from now

4 days ago · Johnson & Johnson agreed to acquire Intra-Cellular Therapies Inc., a company focused on treatments for central nervous system disorders, for about $14.6 billion.

bloomberg.com

$14
OFF

J&J To Buy Psychiatric Drug Developer Intra-Cellular For $14.6B

1 week from now

4 days ago · Johnson & Johnson on Monday said it has agreed to acquire Intra-Cellular Therapies, a developer of drugs for diseases of the brain, for $132 per share, or about $14.6 …

biopharmadive.com

39%
OFF

J&J Acquires CNS Specialist Intra-Cellular For $14.6B

1 week from now

4 days ago · Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% …

fiercepharma.com

$14
OFF

Johnson & Johnson To Acquire Intra-Cellular Therapies For $14.

1 week from now

4 days ago · Johnson & Johnson has announced its acquisition of Intra-Cellular Therapies for approximately $14.6 billion, paying $132 per share in cash. The acquisition includes …

nasdaq.com

$14
OFF

J&J Strikes $14.6 Billion Deal For Intra-Cellular Therapies - Axios

1 week from now

4 days ago · Johnson & Johnson on Monday said that it's agreed to acquire CNS biotech Intra-Cellular Therapies for $14.6 billion in cash, or $132 per share. Why it matters: This would be …

axios.com

$14
OFF

J&J To Acquire Intra-Cellular For About $14.6 Billion (3)

1 week from now

4 days ago · Johnson & Johnson agreed to acquire Intra-Cellular Therapies Inc., a company focused on treatments for central nervous system disorders, for about $14.6 billion.. J&J will …

bloomberglaw.com

70%
OFF

Johnson & Johnson To Acquire Intra-Cellular In $15 Billion Deal

1 week from now

3 days ago · Johnson & Johnson JNJ 1.70% increase; green up pointing triangle agreed to acquire mental-illness drug developer Intra-Cellular Therapies ITCI 34.07% increase; green up …

wsj.com

32%
OFF

Intra-Cellular Therapies Soars 32% With Johnson & Johnson's …

1 week from now

4 days ago · In a move that's shaking up the healthcare space, Johnson & Johnson just sealed a deal to acquire Intra-Cellular Therapies (NASDAQ:ITCI) for $132 per share, valuing the …

yahoo.com

$14
OFF

Johnson & Johnson’s $14.6 Billion Acquisition Of Intra‑Cellular ...

1 week from now

4 days ago · On January 13, 2025, Johnson & Johnson and Intra‑Cellular Therapies, Inc. announced that they have entered into a definitive agreement under which Johnson & …

cravath.com

$14
OFF

Johnson & Johnson Acquires Intra-Cellular Therapies In $14.6bn Deal

1 week from now

3 days ago · Johnson & Johnson has entered an acquisition agreement with drug developer Intra-Cellular Therapies priced at $14.6bn, positioning the deal as one of the largest seen in the …

outsourcing-pharma.com

$14
OFF

Johnson & Johnson To Acquire Intra-Cellular Therapies For $14.6B

1 week from now

Johnson & Johnson (J&J) will acquire neurological drugmaker Intra-Cellular Therapies for about $14.6 billion as it continues to expand its presence in key treatment segments to …

forbesmiddleeast.com

$14
OFF

Caplyta Star Shines As J&J Takes Intra-Cellular In $14.6B Deal

1 week from now

3 days ago · The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire Intra …

bioworld.com

$14
OFF

J&J Agrees $14.6bn Takeover Of CNS Biotech Intra-Cellular

1 week from now

4 days ago · Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share …

pharmaphorum.com

$14
OFF

Rumour Confirmed: J&J To Purchase Intra-Cellular For $14.6B

1 week from now

4 days ago · Johnson & Johnson on Monday announced an agreement to acquire Intra-Cellular Therapies for $132 per share in cash, or a total equity value of approximately $14.6 billion, the …

firstwordpharma.com

$14
OFF

J&J Putting Up $14.6B To Grab Intra-Cellular, Caplyta

1 week from now

4 days ago · Johnson & Johnson (J&J) is taking over central nervous system disorders player Intra-Cellular Therapies Inc. for $132 per share in a deal that puts the total equity value at …

bioworld.com

$14
OFF

Intra-Cellular Therapies Nabs $14.6 Billion Takeover From Johnson ...

1 week from now

3 days ago · Johnson & Johnson kicked off the J.P. Morgan Healthcare Conference on Monday with the $14.6 billion acquisition of Intra-Cellular Therapies. The deal values the smaller …

investors.com

$14
OFF

Johnson & Johnson Acquires Intra-Cellular Therapies For $14.6 Billion

1 week from now

2 days ago · Johnson & Johnson has announced the acquisition of biopharmaceutical company Intra-Cellular Therapies, strengthening its position in the market for central nervous system …

european-biotechnology.com

$14
OFF

Johnson & Johnson To Acquire Intra-Cellular Therapies For $14.6B

1 week from now

4 days ago · Johnson & Johnson announced Monday it will acquire Intra-Cellular Therapies (NASDAQ:ITCI) for approximately $14.6 billion, significantly expanding its portfolio of …

grafa.com

$132.00
OFF

Johnson & Johnson To Acquire Intra-Cellular For $132.00 Per Share …

1 week from now

4 days ago · Johnson & Johnson To Buy Intra-Cellular Therapies For $132.00/shr In $14.6 Bln All-cash Deal RTTNews 3h Johnson & Johnson Strengthens Neuroscience Leadership with …

businessinsider.com

FAQs about Johnson & Johnson Strengthens Neuroscience Leadership with … Coupon?

Does Johnson & Johnson own intra-cellular therapies?

Johnson & Johnson (JNJ) and Intra-Cellular Therapies (ITCI) announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Intra-Cellular Therapies for $132.00 per share in cash for a total equity value of approximately $14.6B. ...

Will Johnson & Johnson buy intra-cellular?

Johnson & Johnson will acquire Intra-Cellular for $132 per share in cash, a 39 percent premium over Intra-Cellular's Friday closing price of $94.87. Following the announcement, shares of both companies rose Monday. The Johnson & Johnson headquarters in New Brunswick, New Jersey, on Feb. 8, 2024. ...

How much does J&J pay for intra-cellular?

Intra-Cellular’s pipeline of drugs under development also includes a potential treatment for anxiety and psychosis and agitation tied to Alzheimer’s disease. That drug is in mid-stage testing. J&J, based in New Brunswick, New Jersey, says it will pay for the deal, valued at about $14.6 billion, with a combination of cash and debt. ...

Did Johnson & Johnson buy ITCI for $15 billion?

Photo: Reuters Johnson & Johnson JNJ 1.70% agreed to acquire mental-illness drug developer Intra-Cellular Therapies ITCI 34.07% for about $15 billion, evidence of the pharmaceutical industry’s renewed interest in neuroscience bets with vast but unrealized promise. ...

What is the difference between intra-cellular & J&J?

Intra-Cellular, based in Bedminster, New Jersey, surged about 34 percent to $127.10, while J&J's stock climbed 1 percent to $143.45. What Is Intra-Cellular? ...

Where is Johnson & Johnson headquartered 2024?

The Johnson & Johnson headquarters in New Brunswick, New Jersey, on Feb. 8, 2024. (AP Photo/Ted Shaffrey, File) Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. ...